A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors
Clinical trial NCT04617314 · COMPLETED
Trial details
- NCT number
- NCT04617314
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2025-12-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.